Biogen (BIIB) Surges Amid Rumors of Acquisition by Samsung

Published on December 30, 2021

Biogen (BIIB) stock gains almost 10% on Dec 29 following speculations over its potential acquisition by the South-Korean conglomerate Samsung Group. However, both parties are yet to confirm.